[go: up one dir, main page]

ZA200804488B - Pyrimidine derivatives for the treatment of abnormal cell growth - Google Patents

Pyrimidine derivatives for the treatment of abnormal cell growth

Info

Publication number
ZA200804488B
ZA200804488B ZA200804488A ZA200804488A ZA200804488B ZA 200804488 B ZA200804488 B ZA 200804488B ZA 200804488 A ZA200804488 A ZA 200804488A ZA 200804488 A ZA200804488 A ZA 200804488A ZA 200804488 B ZA200804488 B ZA 200804488B
Authority
ZA
South Africa
Prior art keywords
treatment
cell growth
abnormal cell
pyrimidine derivatives
pyrimidine
Prior art date
Application number
ZA200804488A
Other languages
English (en)
Inventor
Arcari Joel Thomas
Bhattacharya Samit Kumar
Brosius Arthur Douglas
Luzzio Michael Joseph
Nelson Kendra Louise
Pan Gonghua
Southers James Alfred
Wishka Donn Gregory
Xiao Jun
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA200804488B publication Critical patent/ZA200804488B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
ZA200804488A 2005-12-21 2008-05-23 Pyrimidine derivatives for the treatment of abnormal cell growth ZA200804488B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75270805P 2005-12-21 2005-12-21

Publications (1)

Publication Number Publication Date
ZA200804488B true ZA200804488B (en) 2009-05-27

Family

ID=38038639

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200804488A ZA200804488B (en) 2005-12-21 2008-05-23 Pyrimidine derivatives for the treatment of abnormal cell growth

Country Status (30)

Country Link
US (1) US7820648B2 (xx)
EP (1) EP1966207A2 (xx)
JP (1) JP4332590B2 (xx)
KR (1) KR101060051B1 (xx)
CN (1) CN101346380B (xx)
AP (1) AP2008004488A0 (xx)
AR (1) AR058399A1 (xx)
AU (1) AU2006327871A1 (xx)
BR (1) BRPI0620324A2 (xx)
CA (1) CA2634646C (xx)
CR (1) CR10095A (xx)
DO (1) DOP2006000289A (xx)
EA (1) EA014551B1 (xx)
EC (1) ECSP088563A (xx)
GT (1) GT200600517A (xx)
HN (1) HN2006042221A (xx)
IL (1) IL191555A0 (xx)
MA (1) MA30075B1 (xx)
ME (1) MEP0908A (xx)
NL (1) NL2000375C2 (xx)
NO (1) NO20082338L (xx)
PE (1) PE20071138A1 (xx)
RS (1) RS20080272A (xx)
SV (1) SV2008002969A (xx)
TN (1) TNSN08270A1 (xx)
TW (1) TW200736258A (xx)
UA (1) UA89123C2 (xx)
UY (1) UY30051A1 (xx)
WO (1) WO2007072158A2 (xx)
ZA (1) ZA200804488B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20130602T1 (xx) 2003-07-30 2013-07-31 Rigel Pharmaceuticals, Inc. Spojevi 2,4-pirimidindiamina za uporabu kod lijeäśenja ili spreäśavanja autoimunih bolesti
US20070032514A1 (en) * 2005-07-01 2007-02-08 Zahn Stephan K 2,4-diamino-pyrimidines as aurora inhibitors
US8258129B2 (en) * 2006-07-06 2012-09-04 Boehringer Ingelheim International Gmbh 4-heterocycloalkylpyri(mi)dines, process for the preparation thereof and their use as medicaments
ES2633318T3 (es) * 2006-10-23 2017-09-20 Cephalon, Inc. Derivados bicíclicos fusionados de 2,4-diaminopirimidina como inhibidores de ALK y c-Met
ES2593486T3 (es) 2007-04-18 2016-12-09 Pfizer Products Inc. Derivados de sulfonil amida para el tratamiento del crecimiento celular anómalo
EP2183225A1 (en) 2007-07-17 2010-05-12 Rigel Pharmaceuticals, Inc. Cyclic amine substituted pyrimidinediamines as pkc inhibitors
JP2011505407A (ja) * 2007-12-03 2011-02-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 過剰な又は異常な細胞増殖を特徴とする疾患を治療するためのジアミノピリジン
US8372974B2 (en) * 2008-03-20 2013-02-12 Boehringer Ingelheim International Gmbh Regioselective preparation of substituted pyrimidines
UY31714A (es) * 2008-03-20 2009-11-10 Boehringer Ingelheim Int Preparación selectiva de pirimidinas sustituidas
EA020807B1 (ru) 2008-06-17 2015-01-30 Астразенека Аб Соединения пиридина
EP2161259A1 (de) 2008-09-03 2010-03-10 Bayer CropScience AG 4-Halogenalkylsubstituierte Diaminopyrimidine als Fungizide
US20110071158A1 (en) * 2009-03-18 2011-03-24 Boehringer Ingelheim International Gmbh New compounds
TW201100441A (en) * 2009-06-01 2011-01-01 Osi Pharm Inc Amino pyrimidine anticancer compounds
WO2011018517A1 (en) 2009-08-14 2011-02-17 Boehringer Ingelheim International Gmbh Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives
US8933227B2 (en) 2009-08-14 2015-01-13 Boehringer Ingelheim International Gmbh Selective synthesis of functionalized pyrimidines
US8466155B2 (en) * 2009-10-02 2013-06-18 Boehringer Ingelheim International Gmbh Pyrimidines
TWI513694B (zh) 2010-05-11 2015-12-21 Amgen Inc 抑制間變性淋巴瘤激酶的嘧啶化合物
BR112012029647A2 (pt) 2010-05-21 2016-08-02 Chemilia Ab novos derivados de pirimidinas
US20120244141A1 (en) 2010-09-28 2012-09-27 Boehringer Ingelheim International Gmbh Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
US9133224B2 (en) 2010-11-29 2015-09-15 OSI Pharmaceuticals, LLC Macrocyclic kinase inhibitors
BR112013024378A2 (pt) 2011-03-24 2016-12-13 Chemilia Ab novos derivados de pirimidina
EP2788345B1 (en) 2011-12-09 2020-06-10 Chiesi Farmaceutici S.p.A. Derivatives of 4-hydroxy-1,2,3,4-tetrahydronaphtalen-1-yl urea and their use in the treatment of, inter alia, diseases of the respiratory tract
EP2794598A1 (en) 2011-12-23 2014-10-29 Cellzome Limited Pyrimidine-2,4-diamine derivatives as kinase inhibitors
CN103655577A (zh) * 2012-09-20 2014-03-26 杨育新 一类治疗创伤性脑损伤疾病的化合物及其用途
CN103664957A (zh) * 2012-09-25 2014-03-26 杨子娇 一类治疗房角狭窄的化合物及其用途
CN105130907B (zh) * 2015-07-29 2018-10-16 沈阳药科大学 嘧啶类化合物及其用途
EP3484528B1 (en) 2016-07-18 2020-11-25 Janssen Pharmaceutica NV Tau pet imaging ligands
WO2020023851A1 (en) * 2018-07-26 2020-01-30 Yale University Bifunctional substitued pyrimidines as modulators of fak proteolyse
CA3204383A1 (en) * 2021-01-07 2022-07-14 Rima AL-AWAR Thienyl and cycloalkyl aminopyrimidine compounds as inhibitors of nuak kinases, compositions and uses thereof
EP4277902A4 (en) * 2021-01-07 2024-12-18 Ontario Institute for Cancer Research (OICR) ISOINDOLINONE-AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF NUAK KINASES, COMPOSITIONS AND USES THEREOF

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828511D0 (en) 1998-12-24 1999-02-17 Zeneca Ltd Chemical compounds
GB0004887D0 (en) * 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
GB0004890D0 (en) * 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
WO2003030909A1 (en) 2001-09-25 2003-04-17 Bayer Pharmaceuticals Corporation 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
TWI329105B (en) * 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
AU2003231231A1 (en) 2002-05-06 2003-11-11 Bayer Pharmaceuticals Corporation Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
BR0316680A (pt) * 2002-11-28 2005-10-18 Schering Ag Pirimidinas inibidoras de chk, pdk e akt, sua produção e uso como agentes farmacêuticos
UA80767C2 (en) * 2002-12-20 2007-10-25 Pfizer Prod Inc Pyrimidine derivatives for the treatment of abnormal cell growth
ATE440087T1 (de) * 2003-01-30 2009-09-15 Boehringer Ingelheim Pharma 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen
EP1751143A1 (en) * 2004-05-14 2007-02-14 Pfizer Products Incorporated Pyrimidine derivatives for the treatment of abnormal cell growth
BRPI0510963A (pt) * 2004-05-14 2007-11-20 Pfizer Prod Inc derivados pirimidina para o tratamento do crescimento anormal de células

Also Published As

Publication number Publication date
CR10095A (es) 2008-07-17
EA014551B1 (ru) 2010-12-30
CN101346380B (zh) 2012-02-29
KR20080077026A (ko) 2008-08-20
CA2634646C (en) 2012-04-10
WO2007072158A8 (en) 2008-08-14
TW200736258A (en) 2007-10-01
MEP0908A (xx) 2010-02-10
EP1966207A2 (en) 2008-09-10
HN2006042221A (es) 2010-01-18
NL2000375A1 (nl) 2007-06-25
IL191555A0 (en) 2008-12-29
US20080234303A1 (en) 2008-09-25
WO2007072158A2 (en) 2007-06-28
UY30051A1 (es) 2007-07-31
ECSP088563A (es) 2008-07-30
MA30075B1 (fr) 2008-12-01
JP2009520807A (ja) 2009-05-28
TNSN08270A1 (fr) 2009-10-30
WO2007072158A3 (en) 2007-12-27
SV2008002969A (es) 2010-08-17
KR101060051B1 (ko) 2011-08-29
AP2008004488A0 (en) 2008-06-30
NO20082338L (no) 2008-06-25
AU2006327871A1 (en) 2007-06-28
CN101346380A (zh) 2009-01-14
CA2634646A1 (en) 2007-06-28
DOP2006000289A (es) 2007-07-31
BRPI0620324A2 (pt) 2011-11-08
RS20080272A (sr) 2009-07-15
EA200801287A1 (ru) 2008-10-30
GT200600517A (es) 2007-09-13
NL2000375C2 (nl) 2008-01-03
US7820648B2 (en) 2010-10-26
AR058399A1 (es) 2008-01-30
PE20071138A1 (es) 2007-12-29
UA89123C2 (ru) 2009-12-25
JP4332590B2 (ja) 2009-09-16

Similar Documents

Publication Publication Date Title
ZA200804488B (en) Pyrimidine derivatives for the treatment of abnormal cell growth
TWI369205B (en) Sulfonyl amide derivatives for the treatment of abnormal cell growth
IL172047A0 (en) Pyrimidine derivatives for the treatment of abnormal cell growth
AU2003288603A8 (en) Pyrimidine derivates for the treatment of abnormal cell growth
IL191471A0 (en) Method of treating abnormal cell growth
IL190135A (en) A process for preparing pyrimidindione derivatives
PL1966162T3 (pl) Pochodne pirymidyny
IL202154A0 (en) Novel amide derivative for inhibiting the growth of cancer cells
EG25081A (en) Use of prolines for improving growth and/or yield.
ZA200708591B (en) Pyrimidine derivatives for treatment of hyperproliferative disorders
GB0525080D0 (en) Pyrimidine derivatives
IL178828A0 (en) Pyrimidine derivatives for the treatment of abnormal cell growth
GB0525081D0 (en) Pyrimidine derivatives
ZA200804777B (en) Method of treating abnormal cell growth
IL213474A0 (en) Processes for the preparation of cyclopropyl-amide derivatives
PL377686A1 (pl) Pochodne 4-anilinochinazoliny do leczenia anormalnego wzrostu komórek
PL1959957T3 (pl) Pochodne pirymidyloaminobenzamidu do leczenia neurowłókniakowatości
EP1901770A4 (en) METHOD FOR TREATING GROWTH TROUBLESHOOTING
ZA200803526B (en) Process for stabilization of bacterial cells
GB0516085D0 (en) Treatment of viable cells
HK1114093A (en) Imidazolo-5-yl-2-anilo-pyrimidines as agents for the inhibition of cell proliferation
HK1118290A (en) Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes